Cognizant has revealed that a demand for clinical analytics services from users in the life sciences industry has helped drive strong business in the UK and Europe.

Despite the difficult economic conditions in the region, the outsourcer recently reported a 3.5 percent quarterly increase in European revenue, an 11 percent increase year-on-year, in its first quarter earnings for 2012.

“Primarily our focus is on banking and the financial services in the UK, as well as life sciences and pharmaceuticals. We are seeing good demand in those industries, for example, in life sciences there is demand around clinical data management and commercial analytics,” said Paul Roehrig, assistant VP of corporate strategy at Cognizant.

Cognizant, which counts pharmaceutical company AstraZeneca among its customers, said that customers were focusing more on what was core to their business, and outsourcing what was “contextual”.

For example, Roehrig explained, the core work around analytics might be to extract the meaning and insight from the data, while the outsourced contextual processes would include the cleaning, filtering and management of the information.

“More focus on what is core will help create a more lean organisation and enable more business-efficient decisions,” he said.

Other areas in which Cognizant is seeing more demand include cloud, social and mobile services.

Roehrig added: “We are also having lots of good interest in business process services. [Companies] are looking for end-to-end business process solutions.”

During Q1 2012, Cognizant signed a number of significant contracts, including one for a large SAP programme for a UK utility company, an enterprise application development and maintenance programme for a major consumer goods company and a managed services-based application outsourcing deal with a French life sciences company.

Other UK customers include the Financial Services Authority, O2 and Marks & Spencer.